Vagal tone augmentation to the atrioventricular node in humans: Efficacy and safety of burst endocardial stimulation

被引:9
作者
Rossi, Pietro [1 ]
Bianchi, Stefano [2 ]
Monari, Giancarlo [3 ]
Della Scala, Alberto [4 ]
Porcelli, Daniele [2 ]
Valsecchi, Sergio [4 ]
Canonaco, Sergio [4 ]
Kornet, Lilian [5 ]
Azzolini, Paolo [2 ]
机构
[1] Belcolle Hosp, Electrophysiol & Pacing Unit, Dept Med, Viterbo, Italy
[2] S Giovanni Calibita Fatebenefratelli Hosp, Div Cardiol, Rome, Italy
[3] ENEA, Frascati, RM, Italy
[4] Medtron Italy, Sesto San Giovanni, MI, Italy
[5] Medtron BRC, Maastricht, Netherlands
关键词
Atrial fibrillation; Atrioventricular node; Burst stimulation; Vagal stimulation; CHRONIC ATRIAL-FIBRILLATION; VENTRICULAR RATE CONTROL; QUALITY-OF-LIFE; CARDIAC RESYNCHRONIZATION; PULMONARY VEIN; HEART-FAILURE; ABLATION; RHYTHM; STABILIZATION; IMPLANTATION;
D O I
10.1016/j.hrthm.2010.01.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Control of atrioventricular (AV) nodal conduction by endocardial stimulation of efferent AV nodal vagal fibers [atrioventricular nodal vagal stimulation (AVNS)] is a promising approach for long-term device-based modulation of ventricular rate during atrial fibrillation (AF). However, few data on the efficacy of AVNS delivered as high-frequency stimulus packages (burst AVNS) in humans are available. OBJECTIVE The purpose of this study was to determine whether burst AVNS can to modulate AV nodal conduction during AF and whether burst AVNS delivered during sinus rhythm (SR) in the effective atrial refractory period allows safe implantation of a permanent lead in a position suitable for AVNS. METHODS Twenty patients (10 in SR and 10 in AF) who were candidates for dual-chamber pacemaker implantation for sick sinus syndrome were enrolled in the study. The posteroseptal right atrium was mapped to identify a location at which burst AVNS would achieve AV nodal conduction modulation (lengthening of PR interval in SR and reduction of ventricular rate in AF). Subsequently, a lead was screwed in at that site and burst stimulation (pulse rate 50 Hz, burst duration 180 ms) was delivered at different burst rates, pulse durations, and amplitudes. RESULTS In all SR patients, PR-interval prolongation was evoked at 90 and 120 bursts/minute with pulse durations <= 1 ms. Specifically, the mean voltages required to obtain PR-interval prolongation and advanced AV block were 4.3 +/- 2.2 V and 5.4 +/- 1.8 V (at 90 bursts/minute and 1 ms), respectively. Similarly, ventricular rate reduction was obtained in all AF patients, starting from 90 bursts/minute and 0.5-ms pulse duration (at 5.4 +/- 1.8 V). Ventricular arrhythmias were never induced during AVNS. CONCLUSION Endocardial right atrial burst AVNS reduces ventricular rate during AF. Burst AVNS delivered during SR in the effective atrial refractory period allows optimization of lead positioning for AVNS.
引用
收藏
页码:683 / 689
页数:7
相关论文
共 28 条
  • [1] Atrioventricular (AV) node vagal stimulation by transvenous permanent lead implantation to modulate AV node function: safety and feasibility in humans
    Bianchi, Stefano
    Rossi, Pietro
    Della Scala, Alberto
    Kornet, Lilian
    Pulvirenti, Raffaele
    Monari, Giancarlo
    Di Renzi, Paolo
    Schauerte, Patrick
    Azzolini, Paolo
    [J]. HEART RHYTHM, 2009, 6 (09) : 1282 - 1286
  • [2] Endocardial Transcatheter Stimulation of the AV Nodal Fat Pad: Stabilization of Rapid Ventricular Rate Response During Atrial Fibrillation in Left Ventricular Failure
    Bianchi, Stefano
    Rossi, Pietro
    Della Scala, Alberto
    Kornet, Lilian
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2009, 20 (01) : 103 - 105
  • [3] Ganglionic mechanisms contribute to diminished vagal control in heart failure
    Bibevski, S
    Dunlap, ME
    [J]. CIRCULATION, 1999, 99 (22) : 2958 - 2963
  • [4] Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation - A randomized, controlled study
    Brignole, M
    Menozzi, C
    Gianfranchi, L
    Musso, G
    Mureddu, R
    Bottoni, N
    Lolli, G
    [J]. CIRCULATION, 1998, 98 (10) : 953 - 960
  • [5] Effect of an irregular ventricular rhythm on cardiac output
    Daoud, EG
    Weiss, R
    Bahu, M
    Knight, BP
    Bogun, F
    Goyal, R
    Harvey, M
    Strickberger, SA
    Man, KC
    Morady, F
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (12) : 1433 - &
  • [6] Inappropriate implantable cardioverter-defibrillator shocks in MADIT II
    Daubert, James P.
    Zareba, Wojciech
    Cannom, David S.
    McNitt, Scott
    Rosero, Spencer Z.
    Wang, Paul
    Schuger, Claudio
    Steinberg, Jonathan S.
    Higgins, Steven L.
    Wilber, David J.
    Klein, Helmut
    Andrews, Mark L.
    Hall, W. Jackson
    Moss, Arthur J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (14) : 1357 - 1365
  • [7] Targeting of cardiac autonomic plexus for modulation of intracardiac neural tone
    Gemein, Christopher
    Schauerte, Patrick
    Hatam, Nima
    Rana, Obaida R.
    Saygili, Erol
    Meyer, Christian
    Eickholt, Christian
    Schmid, Michael
    Knackstedt, Christian
    Zarse, Markus
    Mischke, Karl
    [J]. EUROPACE, 2009, 11 (08): : 1090 - 1096
  • [8] Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure
    Hoppe, Uta C.
    Casares, Jaime M.
    Eiskjaer, Hans
    Hagemann, Arne
    Cleland, John G. F.
    Freemantle, Nick
    Erdmann, Erland
    [J]. CIRCULATION, 2006, 114 (01) : 18 - 25
  • [9] Relationship of Paroxysmal Atrial Tachyarrhythmias to Volume Overload Assessment by Implanted Transpulmonary Impedance Monitoring
    Jhanjee, Rajat
    Templeton, Grant A.
    Sattiraju, Srinivasan
    Nguyen, John
    Sakaguchi, Scott
    Lu, Fei
    Ermis, Cengiz
    Milstein, Simon
    Van Heel, Laura
    Lurie, Keith G.
    Benditt, David G.
    [J]. CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (05) : 488 - 494
  • [10] A 12-month quality of life assessment of cardiac arrest survivors treated with or without an implantable cardioverter defibrillator
    Kamphuis, HCM
    De Leeuw, JRJ
    Derksen, R
    Hauer, R
    Winnubst, JAM
    [J]. EUROPACE, 2002, 4 (04): : 417 - 425